Drugging the gut microbiome.

Garber, Ken · Nat Biotechnol · 2015

review · Level V

Where this comes from

Abstract

Using conventional drug discovery and novel synthetic biology approaches, some investigators and companies are mining our resident microbes and their metabolites for targets in small-molecule drug programs. Ken Garber reports.

Medical subject headings